Detalhe da pesquisa
1.
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study.
BMC Gastroenterol
; 22(1): 199, 2022 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35448949
2.
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Crohns Colitis 360
; 6(2): otae023, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38681979
3.
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients.
Therap Adv Gastroenterol
; 16: 17562848231210053, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026104
4.
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial.
Biomedicines
; 11(6)2023 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37371853
5.
Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
Inflamm Intest Dis
; 5(2): 93-97, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984404
6.
Endoscopic activity, tissue factor and Crohn's disease: findings in clinical remission patients.
Therap Adv Gastroenterol
; 13: 1756284820939412, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-34025780
7.
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
World J Gastroenterol
; 25(9): 1142-1157, 2019 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30863001
8.
Guillain-Barré Syndrome in a Crohn`s Disease Patient Treated With Vedolizumab.
J Crohns Colitis
; 14(12): 1788-1789, 2020 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417923
9.
Immune thrombocytopenic purpura induced by intestinal tuberculosis in a liver transplant recipient.
World J Gastroenterol
; 20(25): 8304-8, 2014 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25009408